Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer
NCT ID: NCT04989153
Last Updated: 2021-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
5000 participants
OBSERVATIONAL
2016-03-05
2023-12-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea
NCT02184910
Individually Tailored Strategies for the Precision Prevention of Gastric Cancer and Colorectal Cancer in the Community
NCT03793335
Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer
NCT06301464
An Observational Study for Gastric Cancer in Asymptomatic Carriers of High Risk Helicobacter Pylori
NCT06896370
Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer
NCT01659632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
non-atrophic gastritis
No atrophic gastritis, The OLGA-0 group;OLGA :Operative Link on Gastritis Assessment)
No interventions assigned to this group
mild-moderate atrophic gastritis
The OLGA I-II group;OLGA :Operative Link on Gastritis Assessment)
No interventions assigned to this group
severe atrophic gastritis
The OLGA III-IV group;OLGA :Operative Link on Gastritis Assessment)
pepsinogen
serum pepsinogen diagnosed gastric cancer and precanceous lesion
gastric cancer
gastric cancer
pepsinogen
serum pepsinogen diagnosed gastric cancer and precanceous lesion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pepsinogen
serum pepsinogen diagnosed gastric cancer and precanceous lesion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
25 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jilin City People's Hospital
UNKNOWN
No. 924 Hospital of the People's Liberation Army of China
UNKNOWN
Kunshan Hospital of Traditional Chinese Medicine
UNKNOWN
Chinese PLA General Hospital
OTHER
Sichuan Provincial People's Hospital
OTHER
Affiliated Hospital of Southwest Medical University
OTHER
Zhongshan Hospital Xiamen University
OTHER
Jingzhou Hospital of Traditional Chinese Medicine
UNKNOWN
Changhai Hospital
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yi Zhao, Master
Role: PRINCIPAL_INVESTIGATOR
2nd affiliated hospital of Zhejiang university, school of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jilin City People's Hospital
Jilin, Jilin, China
Chinese PLA General Hospital
Beijing, , China
Sichuan Provincial People's Hospital
Chengdu, , China
The First Hospital affiliated to AMU (Southwest Hospital)
Chongqing, , China
No. 924 Hospital of the People's Liberation Army of China
Guilin, , China
Jingzhou Hospital of Traditional Chinese Medicine
Jingzhou, , China
Kunshan Hospital of Traditional Chinese Medicine
Kunshan, , China
Shanghai Changhai Hospital
Shanghai, , China
Zhongshan Hospital affiliated to Xiamen University
Xiamen, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hong Li
Role: primary
Lirong Gong
Role: primary
Hongbo Wu
Role: primary
Xueqiang He
Role: primary
Yinhu Luo
Role: primary
Hongwei Xu
Role: primary
Dong Wang
Role: primary
Hongzhi Xu
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
研2015-079
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.